Stock Trend Analysis Report
Prepared for you on Friday, December 8, 2023.
Cytokinetics, Incorporated (NASDAQ:CYTK)
Crossroads (+60) - CYTK is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CYTK?
MarketClub looks at technical strength and momentum to determine if the timing is right for CYTK.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for CYTK
The long-term trend has been DOWN since Nov 4th, 2022 at 39.881
The intermediate-term trend has been UP since Dec 7th, 2023 at 35.220
The short-term trend has been UP since Nov 29th, 2023 at 32.235
Smart Scan Analysis for CYTK
Based on our trend formula, CYTK is rated as a +60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|Year High||10.255||Year High Date||2018-01-24|
|Year Low||6.02||Year Low Date||2018-11-14|
|52wk High||47.49||52wk High Date||2022-12-22|
|52wk Low||25.98||52wk Low Date||2023-10-04|
|Year End Close||0.66||Average Volume||1,456,089|
|Shares Outstanding||98,054||Short Interest||750,568|
|% Institutional||68.9||Market Cap||761M|